uridine diphosphate has been researched along with Apoplexy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ansar, S; Edvinsson, L; Erdling, A; Johansson, SE; Radziwon-Balicka, A | 1 |
| Arumugam, TV; Jo, DG; Lai, MKP; Park, J | 1 |
1 review(s) available for uridine diphosphate and Apoplexy
| Article | Year |
|---|---|
O-GlcNAcylation as a Therapeutic Target for Alzheimer's Disease.
Topics: Acetylglucosamine; Aged; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Antigens, Neoplasm; Brain; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucose; Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing); Glycosylation; Hexosamines; Histone Acetyltransferases; Humans; Hyaluronoglucosaminidase; Insulin Resistance; Molecular Structure; Nerve Tissue Proteins; Neurodegenerative Diseases; Neuroprotective Agents; Phosphorylation; Protein Isoforms; Protein Processing, Post-Translational; Stroke; tau Proteins; Uridine Diphosphate; Uridine Diphosphate N-Acetylgalactosamine | 2020 |
1 other study(ies) available for uridine diphosphate and Apoplexy
| Article | Year |
|---|---|
Changes in P2Y
Topics: Animals; Infarction, Middle Cerebral Artery; Ischemia; Rats; Receptors, Purinergic P2; Stroke; Uridine Diphosphate; Vasoconstriction | 2022 |